SARS-CoV-2 antibody avidity responses in COVID-19 patients and convalescent plasma donors

SE Benner, EU Patel, O Laeyendecker… - The Journal of …, 2020 - academic.oup.com
Background Convalescent plasma therapy is a leading treatment for conferring temporary
immunity to COVID-19–susceptible individuals or for use as post-exposure prophylaxis …
被引用次数：113 相关文章

SARS-CoV-2 Antibody Avidity Responses in COVID-19 Patients and Convalescent Plasma Donors.

SE Benner, EU Patel, O Laeyendecker… - The Journal of …, 2020 - europepmc.org
Background Convalescent plasma therapy is a leading treatment for conferring temporary
immunity to COVID-19-susceptible individuals or for use as post-exposure prophylaxis …

SARS-CoV-2 Antibody Avidity Responses in COVID-19 Patients and Convalescent Plasma Donors

SE Benner, EU Patel… - The Journal of …, 2020 - pubmed.ncbi.nlm.nih.gov
Background Convalescent plasma therapy is a leading treatment for conferring temporary
immunity to COVID-19-susceptible individuals or for use as post-exposure prophylaxis …

SARS-CoV-2 Antibody Avidity Responses in COVID-19 Patients and Convalescent Plasma Donors

SE Benner, EU Patel, O Laeyendecker… - The Journal of …, 2020 - academic.oup.com
Background Convalescent plasma therapy is a leading treatment for conferring temporary
immunity to COVID-19–susceptible individuals or for use as post-exposure prophylaxis …

SARS-CoV-2 Antibody Avidity Responses in COVID-19 Patients and Convalescent Plasma Donors

SE Benner, EU Patel, O Laeyendecker… - The Journal of …, 2020 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: sec>< jats: title> Background</jats: title>< jats: p>
Convalescent plasma therapy is a leading treatment for conferring temporary immunity to …
[HTML] nih.gov

[HTML][HTML] SARS-CoV-2 Antibody Avidity Responses in COVID-19 Patients and Convalescent Plasma Donors

SE Benner, EU Patel, O Laeyendecker… - The Journal of …, 2020 - ncbi.nlm.nih.gov
Background Convalescent plasma therapy is a leading treatment for conferring temporary
immunity to COVID-19–susceptible individuals or for use as post-exposure prophylaxis …

SARS-CoV-2 Antibody avidity responses in COVID-19 patients and convalescent plasma donors

SE Benner, EU Patel, O Laeyendecker… - Journal of Infectious …, 2020 - pure.johnshopkins.edu
Background: Convalescent plasma therapy is a leading treatment for conferring temporary
immunity to COVID-19-susceptible individuals or for use as post-exposure prophylaxis …

SARS-CoV-2 antibody avidity responses in COVID-19 patients and convalescent plasma donors.

SE Benner, EU Patel, O Laeyendecker, A Pekosz… - 2020 - cabidigitallibrary.org
Background: Convalescent plasma therapy is a leading treatment for conferring temporary
immunity to COVID-19-susceptible individuals or for use as post-exposure prophylaxis …

SARS-CoV-2 Antibody Avidity Responses in COVID-19 Patients and Convalescent Plasma Donors.

SE Benner, EU Patel, O Laeyendecker… - The Journal of …, 2020 - europepmc.org
Background Convalescent plasma therapy is a leading treatment for conferring temporary
immunity to COVID-19-susceptible individuals or for use as post-exposure prophylaxis …